Assembly Biosciences Correlations
ASMB Stock | USD 16.78 0.72 4.11% |
The current 90-days correlation between Assembly Biosciences and Spero Therapeutics is 0.08 (i.e., Significant diversification). The correlation of Assembly Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Assembly Biosciences Correlation With Market
Average diversification
The correlation between Assembly Biosciences and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Assembly Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Assembly |
Moving together with Assembly Stock
0.74 | DSGN | Design Therapeutics Earnings Call Today | PairCorr |
Moving against Assembly Stock
0.49 | ME | 23Andme Holding | PairCorr |
0.43 | VALN | Valneva SE ADR | PairCorr |
0.4 | DRMA | Dermata Therapeutics | PairCorr |
0.64 | VIRX | Viracta Therapeutics | PairCorr |
0.56 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.45 | CDTTW | Conduit Pharmaceuticals | PairCorr |
0.39 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.37 | VTGN | VistaGen Therapeutics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Assembly Stock performing well and Assembly Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Assembly Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
SPRO | 1.88 | 0.05 | (0.03) | 0.30 | 1.84 | 5.56 | 14.25 | |||
ACHL | 1.97 | 0.32 | 0.15 | 0.41 | 1.54 | 3.03 | 38.16 | |||
TIL | 9.12 | 1.73 | 0.31 | 0.55 | 6.39 | 20.63 | 105.83 | |||
NLTX | 2.25 | (0.20) | 0.00 | (1.30) | 0.00 | 4.05 | 27.84 | |||
CTMX | 2.44 | (0.26) | 0.00 | (0.07) | 0.00 | 5.00 | 17.21 | |||
NUVB | 3.53 | (0.42) | (0.01) | 0.03 | 4.15 | 9.48 | 18.83 | |||
NXTC | 2.19 | (0.30) | 0.00 | (0.91) | 0.00 | 4.49 | 14.18 |
Assembly Biosciences Corporate Management
Nicole White | Chief Officer | Profile | |
AO FRACP | CEO Director | Profile | |
Adam Zlotnick | Chief CoFounder | Profile | |
Amy CFA | Investor Consultant | Profile | |
Uri MD | CoFounder Advisor | Profile | |
Michele Anderson | Chief Officer | Profile |